MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Hepatic fibrosis, unspecified (K74.00)

HealthDay 13 June at 03.46 PM

Tirzepatide Beneficial for Resolution of MASH in Patients With MASH, Fibrosis

For patients with metabolic dysfunction-associated steatohepatitis (MASH) and moderate-to-severe fibrosis, 52 weeks of tirzepatide is more effective than placebo for resolution of MASH, according to a study published online June 8 in the New England Journal of Medicine to coincide with the annual congress of the European Association for the